Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023


☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .

Commission File Number: 001-41214

Western Acquisition Ventures Corp.

(Exact name of registrant as specified in its charter)



Delaware (State or Other Jurisdiction of Incorporation or Organization)		86-3720717 (I.R.S. Employer Identification No.)
	42 Broadway, 12th Floor New York, New York 10004 (Address of principal executive offices)

Registrant’s telephone number, including area code: (310) 740-0710

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol	Name of each exchange on which registered
Units, each consisting of one share of Common Stock and one Warrant to acquire one share of Common Stock	WAVSU	The Nasdaq Stock Market LLC
Common Stock, par value $0.0001 per share	WAVS	The Nasdaq Stock Market LLC
Warrants	WAVSW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer ☐	Accelerated filer ☐		Non-accelerated filer ☒
Smaller reporting company ☒		Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of August 21, 2023, 3,556,410 shares of the registrant’s common stock were outstanding.

Table of Contents

WESTERN ACQUISITION VENTURES CORP.

INDEX


		PAGE NUMBER
PART I FINANCIAL INFORMATION		2

Item 1.	Financial Statements	2

	Condensed Balance Sheets as of June 30, 2023 (unaudited) and December 31, 2022	2

	Unaudited Condensed Statements of Operations for the three and six months ended June 30, 2023 and 2022	3

	Unaudited Condensed Statements of Changes in Stockholders’ (Deficit) Equity for the three and six months ended June 30, 2023 and 2022	4

	Unaudited Condensed Statements of Cash Flows for the six months ended June 30, 2023 and 2022	5

	Notes to Unaudited Condensed Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	27

Item 4.	Controls and Procedures	27

PART II OTHER INFORMATION		28

Item 1.	Legal Proceedings	28

Item 1A.	Risk Factors	28

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28

Item 3.	Defaults Upon Senior Securities	28

Item 4.	Mine Safety Disclosures	28

Item 5.	Other Information	28

Item 6.	Exhibits	29

Table of Contents

FORWARD LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). The statements contained in this Report that are not purely historical are forward-looking statements. Our forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipates,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Report may include, for example, statements about our:

●

ability to complete our initial business combination;

●

success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;

●

officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination, as a result of which they would then receive expense reimbursements;

●

potential ability to obtain additional financing to complete our initial business combination;

●

pool of prospective target businesses;

●

the ability of our officers and directors to generate a number of potential investment opportunities;

●

potential change in control if we acquire one or more target businesses for stock;

●

the potential liquidity and trading of our securities;

●

the lack of a market for our securities;

●

use of proceeds not held in the trust account or available to us from interest income on the trust account balance;

●

financial performance following our initial public offering; or

●

depleting resources available for an initial business combination on negotiations and diligence of a target that ultimately does not consummate such that remaining resources are insufficient to complete an initial business combination with another target.

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in our filings with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 31, 2023 (the “2022 Annual Report”), and our subsequent reports, including this Report and Current Reports on Form 8-K. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws or if management knows or has a reasonable basis on which to conclude that previously disclosed projections are no longer reasonably attainable.

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

WESTERN ACQUISITION VENTURES CORP.

CONDENSED BALANCE SHEETS


	June 30, 2023		December 31, 2022
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	258,551	$	809,481
Prepaid expenses and other assets		188,075		268,208
Total current assets		446,626		1,077,689

Prepaid expenses - non current		—		17,868
Investments held in Trust Account		8,097,937		117,191,410
TOTAL ASSETS	$	8,544,563	$	118,286,967
LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	946,883	$	829,440
Derivative liability-Forward Purchase Agreement		597,285		—
Excise tax payable		1,094,366		—
Income tax payable		305,562		250,739
Franchise tax payable		22,000		163,200
Total liabilities		2,966,096		1,243,379

COMMITMENTS AND CONTINGENCIES (Note 6)
REDEEMABLE COMMON STOCK
Common stock subject to possible redemption, $0.0001 par value, 770,221 shares and 11,500,000 shares at redemption value of approximately $10.55 and $10.20 per share as of June 30, 2023 and December 31, 2022, respectively		8,129,583		117,299,975

STOCKHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—		—
Common stock; $0.0001 par value; 50,000,000 shares authorized; 3,251,000 shares issued and outstanding (excluding 770,221 shares and 11,500,000 shares, respectively, subject to possible redemption) as of June 30, 2023 and December 31, 2022		324		324
Additional paid-in capital		—		1,605,560
Accumulated deficit		(2,551,440)		(1,862,271)
Total stockholders’ deficit		(2,551,116)		(256,387)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS’ DEFICIT	$	8,544,563	$	118,286,967

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

WESTERN ACQUISITION VENTURES CORP.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
OPERATING EXPENSES
Professional fees and other expenses	$	(187,706)	$	(831,761)	$	(543,125)	$	(1,316,609)
Franchise tax		(11,000)		(50,000)		(22,050)		(95,839)
LOSS FROM OPERATIONS		(198,706)		(881,761)		(565,175)		(1,412,448)
Other (expense) income:
Interest earned and unrealized loss on marketable securities held in Trust Account		93,954		159,361		283,114		99,639
Change in fair value of forward purchase agreement		(210,365)		—		(167,264)		—
TOTAL OTHER (LOSS) INCOME BEFORE TAXES		(315,117)		(722,400)		(449,325)		(1,312,809)
Income Tax Expense		(17,420)		—		(54,823)		—
NET LOSS	$	(332,537)	$	(722,400)	$	(504,148)	$	(1,312,809)
Weighted average shares outstanding of Common Stock subject to possible redemption		770,221		11,500,000		1,363,026		10,610,497
Basic and diluted net loss per share, Common Stock subject to possible redemption	$	(0.08)	$	(0.05)	$	(0.11)	$	(0.09)
Weighted average shares outstanding of Common Stock not subject to possible redemption		3,251,000		3,251,000		3,251,000		3,221,917
Basic and diluted net loss per share, Common Stock not subject to possible redemption	$	(0.08)	$	(0.05)	$	(0.11)	$	(0.09)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

WESTERN ACQUISITION VENTURES CORP.

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

(UNAUDITED)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023


				Additional				Total
	Common stock			paid-in		Accumulated		stockholders’
	Shares	Amount		capital		deficit		deficit
Balance December 31, 2022	3,251,000	$	324	$	1,605,560	$	(1,862,271)	$	(256,387)
Forward purchase agreement	—		—		(430,021)		—		(430,021)
Excise tax liability arising from redemption of shares	—		—		(1,094,366)		—		(1,094,366)
Accretion of Common Stock subject to possible redemption to redemption value	—		—		(81,173)		(89,488)		(170,661)
Net loss	—		—		—		(171,611)		(171,611)
Balance March 31, 2023	3,251,000	$	324	$	—	$	(2,123,370)	$	(2,123,046)
Accretion of Common Stock subject to possible redemption to redemption value	—		—		—		(95,533)		(95,533)
Net loss	—		—		—		(332,537)		(332,537)
Balance June 30, 2023	3,251,000	$	324	$	—	$	(2,551,440)	$	(2,551,116)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022


								Total
	Common stock			Additional		Accumulated		stockholders’
	Shares	Amount		paid-in capital		deficit		equity
Balance December 31, 2021	2,875,000	$	287	$	24,713	$	(11,371)	$	13,629
Sale of private placement units including over-allotment	376,000		37		3,759,963		—		3,760,000
Proceeds allocated to public warrants, net of offering costs	—		—		3,533,617		—		3,533,617
Accretion for Common Stock subject to possible redemption to redemption value	—		—		(5,712,733)		—		(5,712,733)
Net Loss	—		—		—		(590,409)		(590,409)
Balance March 31, 2022	3,251,000		324		1,605,560		(601,780)		1,004,104
Net loss	—		—		—		(722,400)		(722,400)
Balance June 30, 2022	3,251,000	$	324	$	1,605,560	$	(1,324,180)	$	281,704

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

WESTERN ACQUISITION VENTURES CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(UNAUDITED)


	For the Six Months Ended June 30,
	2023		2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(504,148)	$	(1,312,809)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned and unrealized loss on marketable securities held in Trust Account		(283,114)		(99,639)
Change in fair value of derivative liability – Forward Purchase Agreement		167,264		—
Changes in operating assets and liabilities:
Prepaid expenses and other assets		98,001		(441,033)
Accounts payable, accrued expenses and income tax payable		172,267		775,784
Franchise tax payable		(141,200)		93,343
Net cash used in operating activities		(490,930)		(984,354)

CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited to Trust Account		(60,000)		(116,150,000)
Cash withdrawn from Trust Account in connection with redemption		109,436,586		—
Net cash provided by (used in) investing activities		109,376,586		(116,150,000)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from initial public offering, net of underwriters’ discount		—		114,500,000
Proceeds from private placement		—		3,760,000
Redemption of Common Stock		(109,436,586)		—
Payment of Sponsor loan		—		(80,000)
Payment of offering costs		—		(431,000)
Net cash (used in) provided by financing activities		(109,436,586)		117,749,000

NET CHANGE IN CASH		(550,930)		614,646
CASH, BEGINNING OF PERIOD		809,481		3,913
CASH, END OF PERIOD	$	258,551	$	618,559

Supplemental disclosure of noncash activities:
Issuance of Forward Purchase Agreement	$	430,021	$	—
Excise tax liability arising from redemption of shares	$	1,094,366	$	—
Accretion of common stock subject to redemption value	$	266,194	$	5,712,733

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

WESTERN ACQUISITION VENTURES CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

June 30, 2023

Note 1 – Description of Organization and Business Operations and Liquidity

Western Acquisition Ventures Corp. (the “Company”) was incorporated in Delaware on April 28, 2021. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities (a “Business Combination”).

The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company, and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of June 30, 2023, the Company had not commenced any operations. All activity from April 28, 2021 (inception) through June 30, 2023, relates to the Company’s formation and Initial Public Offering (“IPO”), which is described below, and, since the IPO, the search for a prospective Business Combination. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income earned on investments from the proceeds derived from the IPO. The registration statement for the Company’s IPO was declared effective on January 11, 2022. On January 14, 2022, the Company consummated the IPO of 10,000,000 units (“Units”) with respect to the common stock included in the Units being offered (the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $100,000,000. Each Unit consists of one share of common stock and one redeemable warrant (the “Public Warrants”). Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7). The Company has selected December 31 as its fiscal year end.

Simultaneously with the closing of the IPO the Company consummated the sale of 361,000 private placement units (“Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Company’s sponsor, Western Acquisition Ventures Sponsor LLC (the “Sponsor”), generating gross proceeds of $3,610,000 which is described in Note 4.

Simultaneously with the closing of the IPO, and the sale of the Private Placement Units, the Company consummated the closing of the sale of 1,500,000 additional Units upon receiving notice of the underwriter’s election to fully exercise its overallotment option (“Overallotment Units”), generating additional gross proceeds of $15,000,000. Simultaneously with the exercise of the overallotment option, the Company consummated the private placement of an additional 15,000 Private Placement Units to the Sponsor, generating gross proceeds of $150,000.

As of June 30, 2023, offering costs for the IPO amounted to $1,029,116, consisting of $500,000 of underwriting fees and $529,116 of other costs. The Company was to pay Alliance Global Partners (“A.G.P.”) a business combination marketing agreement fee in an amount equal to 4.5% of the gross proceeds of the IPO (an aggregate amount due to A.G.P of $5,175,000) if the Company is successful in completing a Business Combination from the amounts being held in the Trust Account (as defined below). If the Company is not successful in completing a Business Combination, A.G.P. will not be entitled to any of this fee (see Note 6). In connection with the Business Combination contemplated with Cycurion, A.G.P., and the Company amended the fee arrangement whereby rather than the cash fee described above, the Company will distribute 250,000 shares of common stock.

Following the closing of the IPO and Overallotment Units, $116,150,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO and the Private Placement Units was placed in a trust account (“Trust Account”). The amounts placed in the Trust Account will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less, or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3), and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, and (ii) the distribution of the Trust Account, as described below.

Table of Contents

Substantially, all of the net proceeds of the IPO and the sale of the Private Placement Units are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the amounts due under the business combination marketing agreement and taxes payable on income earned on the Trust Account) at the time of the agreement to enter into the Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance the Company will be able to successfully effect such a Business Combination.

The Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either: (i) in connection with a stockholder meeting called to approve the Business Combination; or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., Public Warrants), the initial carrying value of the Public Shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options.” The Public Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either: (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument; or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the balance sheet until such date that a redemption event takes place.

Redemptions of the Company’s Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to the Company’s Business Combination. If the Company seeks stockholder approval of the Business Combination, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required by law or stock exchange rule. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.

Notwithstanding the foregoing, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares sold in the IPO, without the prior consent of the Company.

Table of Contents

The Company’s Sponsor, officers, and directors (the “Initial Stockholders”) have agreed not to propose an amendment to the Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their shares of common stock in conjunction with any such amendment.

On January 6, 2023, the Company voted upon and approved a Charter Amendment to be filed with the Delaware Secretary of State and on the Trust Agreement Amendment (collectively known as the “Amendment Agreements”). The Amendment Agreements permit an extension of the date by which the Company has to consummate a business combination up to six times, each such extension for an additional one month period, from January 11, 2023 to July 11, 2023, upon payments to the Trust Account of $10,000 for each one-month extension. On July 9, 2023, the Company voted upon and approved a Second Charter Amendment to be filed with the Delaware Secretary of State and on the Trust Agreement Amendment. The Second Amendment Agreements permit an extension of the date by which the Company has to consummate a business combination to January 11, 2024 upon the payment of a nominal fee of $100.

If the Company is unable to complete a Business Combination by January 11, 2024, (the “Combination Period”), the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay: (a) its income and franchise taxes and (b) up to $100,000 of dissolution expenses, if any, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve, and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

On January 6, 2023, at a special meeting of stockholders, the Company’s stockholders elected to redeem an aggregate of 10,729,779 shares, each share valued at approximately $10.20 per share and totaling $109,436,586.

On April 3, 2023, the Company received a notice in the form of a letter (the “Notice”) from the listing qualifications department staff of The Nasdaq Stock Market notifying the Company that for the last 30 consecutive business days, the Company’s Minimum Value of Listed Securities (“MVLS”) was below the minimum of $50 million required for continued listing on the Nasdaq Global Market pursuant to Nasdaq listing rule 5450(b)(2)(A). The Notice has no immediate effect on the listing of the Company’s common stock, warrants and units, and the Company’s common stock continues to trade on the Nasdaq Global Market under the symbols “WAVS,” “WAVSW” and “WAVSU,” respectively. In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until October 2, 2023, to regain compliance. The Notice states that to regain compliance, the Company’s MVLS must close at $50 million or more for a minimum of ten consecutive business days during the compliance period ending October 2, 2023. The Company could alternatively apply for listing on the Nasdaq Capital Market, which it expects to do. If the Company does not regain compliance by October 2, 2023, Nasdaq staff will provide written notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a Nasdaq hearings panel. The Company intends to actively monitor the Company’s MVLS between now and October 2, 2023, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the MVLS rule.

Separately, NASDAQ has asked the Company us to produce evidence relative to its qualification for continued listing based on the number of record and beneficial holders of the Company. In order to maintain such listing it needs to have a minimum of 300 beneficial owners of its shares, The Company is in the process of obtaining the information to demonstrate compliance.

While the Company is exercising diligent efforts to maintain the listing of its common stock on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance with Nasdaq listing standards.

Table of Contents

The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, since the Initial Stockholders acquired Public Shares in the IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. A.G.P. has agreed to waive its rights to its business combination marketing agreement fee (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10 per share held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who has executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements waiving any right, title, interest, or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these unaudited condensed financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements.

Business Combination Agreement

On November 21, 2022, the Company, WAV Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), which will be formed at, or prior to, closing, Cycurion, Inc., a corporation organized under the laws of Ontario (“Cycurion”), and Emmit McHenry as Cycurion stockholders’ representation (the “Stockholders’ Representative”), entered into an Agreement and Plan of Merger (“Merger Agreement”) pursuant to which, among other things, Cycurion will be merged with the Merger Sub (the “Merger,” and together with the other transactions related thereto, the “Proposed Transactions”), with Cycurion surviving the Merger as a wholly-owned subsidiary of Registrant (the “Surviving Corporation”). There is no guarantee that a merger will take place.

Sponsor Support Agreement

Contemporaneously with the execution of the Merger Agreement, the Sponsor, a Delaware limited liability company, delivered the Support Agreement, pursuant to which, among other things, Sponsor agreed to vote in favor of the Merger and the transactions contemplated by the Merger Agreement.

Table of Contents

Stockholder Support Agreement

Contemporaneously with the execution of the Merger Agreement, certain officers and directors of the Company delivered Support Agreements, pursuant to which, among other things, the Company’s stockholders agreed to vote in favor of the Merger and the transactions contemplated by the Merger Agreement. In addition, the Company agreed to use its best efforts to obtain additional Stockholder Support Agreements from certain of its stockholders.

Registration Rights Agreement

In connection with the Closing, Cycurion, the Company, and certain of their respective stockholders will enter into a registration rights agreement (the “Registration Rights Agreement”). Pursuant to the Registration Rights Agreement, the Combined Company will be required to file a registration statement covering the resale of registrable securities held by the stockholders.

Termination

The Merger Agreement may be terminated at any time prior to the consummation of the Merger by mutual written consent of Cycurion, as applicable, and Company, and in certain other limited circumstances, including if the Merger has not been consummated by January 11, 2024. Either the Company or Cycurion may also terminate the Merger Agreement if certain Proposals fail to receive the requisite vote for approval, and other conditions, as defined in the Merger Agreement. If the Merger Agreement is terminated, the Merger Agreement, and all above agreements, will become void, and there will be no liability under the Merger Agreement on the part of any party thereto, except as set forth in the Merger Agreement.

Liquidity and Capital Resources

As of June 30, 2023, the Company had $258,551 in its operating bank accounts, and a working capital deficit of $2,191,908.

Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating, and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors, and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing.

If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.

Going Concern

In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution described in Note 1, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance of these financial statements.

Table of Contents

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP for audited financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three and six months ended June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future interim periods.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto, included in the Form 10-K annual report filed by the Company with the SEC on March 31, 2023.

Emerging Growth Company

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the “JOBS Act”) which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of revenues and expenses during the reporting period.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $258,551 and $809,481 in cash and did not have any cash equivalents as of June 30, 2023 and December 31, 2022, respectively.

Investments Held in Trust Account

At June 30, 2023 and December 31, 2022, substantially all of the assets held in the Trust Account were held in mutual funds that invest in U.S Treasury Securities. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information.

Common Stock subject to Possible Redemption

Table of Contents

the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Public Shares sold in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, on January 14, 2022, 11,500,000 shares of common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

Immediately upon the closing of the IPO, the Company recognized the accretion from the initial book value to redemption amount value. This method would view the end of the reporting period as if it were also the redemption date for the security. The change in the carrying value of redeemable shares of common stock resulted in charges against additional paid-in capital.

As of June 30, 2023 and December 31, 2022, the value of common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Gross proceeds	$	115,000,000
Less:
Proceeds allocated to Public Warrants		(3,565,000)
Issuance costs allocated to Public Shares		(997,733)
Plus:
Accretion of carrying value to redemption value		6,862,708
Common stock subject to possible redemption as of December 31, 2022	$	117,299,975
Less:
Redemption		(109,436,586)
Add:
Accretion of carrying value to redemption value		170,661
Common stock subject to possible redemption as of March 31, 2023	$	8,034,050
Add:
Accretion of carrying value to redemption value		95,533
Common stock subject to possible redemption as of June 30, 2023	$	8,129,583

Deferred Offering Costs Associated with the Initial Public Offering

Deferred offering costs consist of direct costs incurred through the balance sheet date that were directly related to the IPO and that were charged to stockholders’ equity upon the completion of the IPO. As of June 30, 2023 and December 31, 2022, the Company has zero deferred offering costs on the balance sheet, due to the IPO taking place in the first calendar quarter of the year ending December 31, 2022.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2023 and December 31, 2022, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature, except for the Investments held in Trust Account and the Derivative Liability - Forward Purchase Agreement.

Fair Value of Derivative Liabilities – Forward Purchase Agreement

Table of Contents

period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The FPA is valued using a Probability Weighted Expected Return Method (“PWERM”) and certain components of the FPA are valued under the Monte Carlo model (see note 8).

Income Taxes

The Company complies with the accounting and reporting requirements of ASC 740, “Income Taxes,” (“ASC 740”) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

The Company’s effective tax rate was -5.53% and 0.00% for the three months ended June 30, 2023 and 2022, respectively, and -12.20% and 0.00% for the six months ended June 30, 2023 and 2022, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three and six months ended June 30, 2023 and 2022, due to the valuation allowance on the deferred tax assets.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2023 and 2022. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties for the three and six months ended June 30, 2023. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

Net Loss per Common Stock Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income or loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The weighted average number of shares outstanding were reduced for the effect of an aggregate of 375,000 Founders Shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. Since the over-allotment was exercised, no forfeiture happened. The 11,876,000 potential shares of common stock for outstanding Public Warrants and Private Placement Warrants (as defined in Note 4) to purchase the Company’s stock were excluded from diluted earnings per share for the three and six months periods ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. As a result, diluted loss per share is the same as basic income or loss per share for the periods presented.

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30,								Six Months Ended June 30,
	2023				2022				2023				2022
	Common		Common		Common		Common		Common		Common		Common		Common
	stock		stock not		stock		stock not		stock		stock not		stock		stock not
	subject to		subject to		subject to		subject to		subject to		subject to		subject to		subject to
	possible		possible		possible		possible		possible		possible		possible		possible
	redemption		redemption		redemption		redemption		redemption		redemption		redemption		redemption
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(63,694)	$	(268,843)	$	(563,189)	$	(159,211)	$	(148,930)	$	(355,218)	$	(1,007,023)	$	(305,786)
Denominator:
Basic and diluted weighted average shares outstanding		770,221		3,251,000		11,500,000		3,251,000		1,363,026		3,251,000		10,610,497		3,221,917
Basic and diluted net loss per ordinary share	$	(0.08)	$	(0.08)	$	(0.05)	$	(0.05)	$	(0.11)	$	(0.11)	$	(0.09)	$	(0.09)

Table of Contents

Accounting for Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants and Private Placement Warrants issued pursuant to the warrant agreement qualify for equity accounting treatment.

Recent Accounting Pronouncements

In June 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). This update requires financial assets measured at amortized cost basis to be presented at the net amount expected to be collected. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectibility of the reported amount. Since June 2016, the FASB issued clarifying updates to the new standard including changing the effective date for smaller reporting companies. The guidance is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU 2016-13 on January 1, 2023. The adoption of ASU 2016-13 did not have a material impact on its financial statements.

The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3 — INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

Pursuant to the IPO, the Company sold 11,500,000 Units (including 1,500,000 Overallotment Units) at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one Public Warrant. Each Public Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

NOTE 4 — PRIVATE PLACEMENT UNITS

On January 14, 2022, simultaneously with the consummation of the IPO and sale of the Overallotment Units, the Company consummated the issuance and sale of 376,000 Private Placement Units in a private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,760,000. Each Private Placement Unit consists of one share of common stock and one warrant (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

A portion of the proceeds from the Private Placement Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and any underlying securities will become worthless.

NOTE 5 — RELATED PARTY TRANSACTIONS

Founder Shares

On June 9, 2021, the Sponsor acquired 4,312,500 shares of common stock of the Company (the “Founder Shares”) for an aggregate purchase price of $25,000. On June 16, 2021, the Sponsor transferred 1,207,500 of the Founder Shares to an affiliate of A.G.P. for $7,000. On November 22, 2021, the Company effected a 2 for 3 reverse stock split of its common stock, and A.G.P. sold back to the Sponsor 55,000 Founder Shares for $478, such that the Sponsor owns an aggregate of 2,125,000 Founder Shares, and A.G.P. owns 750,000 Founder Shares. Up to 375,000 Founder Shares (including the Founder Shares transferred to an affiliate of A.G.P.) were subject to forfeiture by the subscribers in case the underwriters did not fully exercise their over-allotment option. Since the underwriters exercised the overallotment option in full on January 14, 2022, none of the Founder Shares are subject to forfeiture any longer.

Table of Contents

The Initial Stockholders have agreed, subject to limited exceptions, not to transfer, assign, or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Business Combination or (B) subsequent to the Business Combination, (x) if the last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities, or other property.

Promissory Note – Related Party

On June 9, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to a promissory note (the “Note”). This Note was amended to become payable on the earlier of the IPO or December 31, 2022. The Note was non-interest bearing and became payable on the consummation of the IPO (January 14, 2022). On December 31, 2021, the balance outstanding on the Note was $80,000 which was subsequently repaid on January 14, 2022 in full.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. These units would be identical to the Private Placement Units. As of June 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding.

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Table of Contents

Underwriting Agreement

The Company granted the underwriters a 45-day option from the final prospectus relating to the IPO to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On January 14, 2022, the underwriters fully exercised their over-allotment option and purchased 1,500,000 Units at $10.00 per Unit.

The underwriters were paid an underwriting fee of $500,000 at the closing of the IPO. As an additional underwriting fee, on June 16, 2021, the Sponsor transferred 1,207,500 of the Founder Shares to an affiliate of A.G.P. for $7,000. On November 22, 2021, the Company effected a 2 for 3 reverse stock split of its common stock, and A.G.P. sold back to the Sponsor 55,000 Founder Shares for $478, such that A.G.P. owns 750,000 Founder Shares.

Business Combination Marketing Agreement

The Company has engaged A.G.P. as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholders’ approval for a Business Combination, and assist the Company with its press releases and public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds of the IPO, or $5,175,000 in the aggregate (exclusive of any applicable finders’ fees that might become payable). In connection with the Business Combination contemplated with Cycurion, A.G.P. and the Company amended the fee arrangement whereby rather than the cash fee described above, the Company will distribute 250,000 shares of common stock.

Table of Contents

Forward Purchase Agreement

On January 10, 2023, the Company, Cycurion, and Alpha Capital Anstalt (“Alpha”), entered into a Forward Share Purchase Agreement (the “FPA”). Prior to effecting the FPA, Alpha had purchased shares from an unaffiliated party which had elected to redeem 300,000 shares of Common Stock, par value $0.0001 per share (such purchased Shares, the “Recycled Shares”.) Under the terms of the FPA, once the proposed Business Combination is effective, and twelve months (or six to nine months if submitted in writing to the Company) have elapsed, Alpha may elect to sell and transfer to the Company up to that number of shares that are then held by Alpha, and the Company shall purchase from Alpha, up to that number of shares that are then held by Alpha, but not to exceed 300,000 shares in the aggregate unless otherwise agreed to in writing by all parties, at a price per share equal to the Redemption Price (as defined in the charter.)

The FPA provides that subject to conditions under the FPA on the date that is 12 months after the closing of the Business Combination (the “BC Closing”); provided that, Alpha, at Alpha’s sole discretion, may accelerate such date to any of six (6) months after the BC Closing and nine (9) months after the BC Closing by providing notice to WAVS of its election to so accelerate at least two (2) calendar days prior to such date (any such date, the “Put Date”), Alpha may elect to sell and transfer to WAVS up to that number of Shares that are then held by Alpha, but not to exceed 300,000 Shares in the aggregate at a price per Recycled Share equal to the Redemption Price (as defined in Section 9.2(a) of the Current Charter) (the “Shares Purchase Price”). The Put Date may be accelerated by Alpha if (i) the Shares are delisted from the New York Stock Exchange of NASDAQ, (ii) the Agreement is terminated for any reason after the date redemption requests are due in connection with the stockholder vote to approve the Business Combination, or (iii) during any 30 consecutive trading day period following the closing of the Business Combination, the VWAP Price (as defined below) for 20 trading days during such period shall be less than $3.00 per Share. For purposes of this Agreement, the “VWAP Price” per Share shall be determined for any trading day or any specified trading period using the Rule 10b-18 volume weighted average price per share of Common Stock as reported via a Bloomberg Terminal. The FPA also provides that WAV shall reimburse Alpha for all reasonable and necessary brokerage commissions incurred in connection with the Alpha’s acquisition of Shares, in an amount not to exceed $0.05 per Share and $0.02 per disposition of each Share.

Simultaneously with the BC Closing, WAVS shall transfer into an escrow account for the benefit of Alpha (the “Escrow Account”) with American Stock Transfer & Trust Company (the “Escrow Agent”), subject to the terms of a customary written escrow agreement (the “Escrow Agreement”) to be entered into on or prior to the BC Closing, an amount equal to the Shares Purchase Price multiplied by the number of Shares held by Alpha as of the closing of the Business Combination (the “Escrowed Funds”). The Escrow Agreement shall irrevocably cause the Escrow Agent to release from the Escrow Account the aggregate Shares Purchase Price on the Put Date, and the additional payments to be made to Alpha described below, if applicable.

Within three business days of receipt by the Escrow Agent and WAVS of written notice that Alpha has sold Recycled Shares the Escrow Agent will release to WAVS an aggregate cash amount equal to (x) the number of Shares sold multiplied by the Reset Price (as defined below) at the time of such sale, and shall release to Alpha an amount in cash equal to the product of (I) the number of Shares sold in the open market multiplied by (II) the difference of (A) the Shares Purchase Price minus (B) the Reset Price. The Reset Price shall initially equal $8.00. The Reset Price shall be adjusted first on the one month anniversary of the BC Closing, and then every three month anniversary of the most recent reset date (each such date, a “Reset Date”) to be the lowest of (a) the then-current Reset Price, (b) $8.00 and (c) an amount equal to the product of (i) 1.05 multiplied by (ii) the VWAP Price of the last five (5) trading days immediately preceding the applicable Reset Date, but not lower than $2.00; provided, however, that if WAVS offers and sells or issues any shares or debt or securities that are convertible into or exchangeable or exercisable for shares (including, but not limited to, any equity line of credit or similar facility determined based on the per share price of any draw by WAVS on such facility (with notice of any such draw to be provided to Investor within one (1) business day of such draw), and excluding securities issued or issuable as merger consideration in connection with the Business Combination Agreement, with such exclusion applicable only to the extent the terms and related agreements are not amended with respect to such securities), at a price lower than, or upon any conversion or exchange or exercise price of currently outstanding or future issuances of any securities convertible or exchangeable or exercisable for shares (other than any incentive equity outstanding immediately following the closing of the Business Combination, with such exclusion applicable only to the extent the terms and related agreements are not amended with respect to such securities) being equal to a price lower than, the then-current Reset Price (the “Offering Price”), then immediately after such event, the Reset Price shall be further reduced to equal the Offering Price.

Table of Contents

The Company accounts for its Forward Purchase Agreement in accordance with the guidance contained in ASC 815-40, under which the FPA does not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classifies the FPA as a liability at its fair value and adjusts the FPA to fair value at each reporting period. These liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The FPA is valued using PWERM and Recycled Shares of the FPA are valued under the Monte Carlo model. The initial fair value of the Forward Purchase Agreement as of January 10, 2023, was $430,021. The fair value of the Forward Purchase Agreement as of June 30, 2023 was $597,285, which resulted in a change in fair value of the Forward Purchase Agreement of $210,365 and $167,264 recorded in the statements of operations for the three and six months ended June 30, 2023, respectively. (See Note 8)

Inflation Reduction Act of 2022 (the “IR Act”)

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company’s ability to complete a business combination.

On January 6, 2023, the Company’s stockholders redeemed 10,729,779 shares of Common Stock for a total of $1,094,366 of excise tax liability calculated as 1% of the value of the shares redeemed on January 6, 2023.

NOTE 7 — STOCKHOLDERS’ DEFICIT

Common Stock —The Company is authorized to issue 50,000,000 shares of common stock with a par value of $0.0001 per share. As of June 30, 2023 and December 31, 2022, there were 3,251,000 shares of common stock outstanding (comprised of 2,875,000 Founder Shares and 376,000 shares of common stock included in the sale of the Private Placement Units and excluding 770,221 shares and 11,500,000 shares of common stock subject to possible redemption, respectively, at June 30, 2023 and December 31, 2022.)

Preferred Stock —The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting, and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of June 30, 2023 and December 31, 2022, there were no shares of preferred stock issued or outstanding.

Table of Contents

Public Warrants — As of June 30, 2023 and December 31, 2022, there were 11,500,000 Public Warrants outstanding. The Company accounts for the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the IPO. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.

The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

●

in whole and not in part;

●

at a price of $0.01 per Public Warrant;

●

upon not less than 30 days’ prior written notice of redemption;

●

if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the Public Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

●

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

The exercise price and number of shares of common stock issuable on exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire and become worthless.

In addition, if (a) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.

Table of Contents

Private Placement Warrants— As of June 30, 2023 and December 31, 2022, there were 376,000 Private Placement Warrants outstanding. The Company accounts for the Private Placement Warrants as equity instruments. The Private Placement Warrants sold in the private placement are identical to the Public Warrants underlying the Units sold in the IPO, except that such warrants, and the shares of common stock issuable upon the exercise of such warrants, will not be transferable, assignable, or salable until after the completion of a Business Combination, subject to certain limited exceptions.

On May 2, 2022, the Company issued a press release, announcing that separate trading of shares of the Common Stock and Warrants comprising the Units has commenced. Any Units not separated will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “WAVSU.” The Common Stock and Warrants will separately trade on Nasdaq under the symbols “WAVS” and “WAVSW,” respectively.

NOTE 8 — FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and nonfinancial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

Level 1 — Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 — Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2023 and December 31, 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:


			Quoted		Significant		Significant
			Prices In		Other		Other
			Active		Observable		Unobservable
	June 30,		Markets		Inputs		Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	8,097,937	$	8,097,937	$	—	$	—
Liabilities:
Derivative Liability - Forward Purchase Agreement	$	597,285	$	—	$	—	$	597,285

Quoted

Significant

Prices In

Other

Active

Observable

Unobservable

December 31,

Markets

Inputs

2022

(Level 1)

(Level 2)

(Level 3)

Assets:

U.S. Money Market held in Trust Account

117,191,410

—

Table of Contents

The FPA is valued using PWERM and Reset Pricing and counterparty sales of Recycled Shares was modeled using a Monte Carlo simulation based on the stock price, settlement timing and market implied volatility. The PWERM is a multistep process in which value is estimated based on the probability-weighted present value of various future outcomes. The estimated fair value of the FPA liability is determined using Level 3 inputs. Inherent in the pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the FPA. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the FPA. The expected life of the FPA is assumed to be equivalent to its remaining contractual term. The initial fair value of the Forward Purchase Agreement as of January 10, 2023, was $430,021. The fair value of the Forward Purchase Agreement as of June 30, 2023 was $597,285, which resulted in a change in fair value of the Forward Purchase Agreement of $210,365 and $167,264 recorded in the statement of operations for the three and six months ended June 30, 2023, respectively.

The key inputs of the models used to value the Company’s FPA were as follows:


	Initial Measurement Date of
Input	January 10, 2023			June 30, 2023
Risk-free interest rate		4.63	%		5.42	%
Remaining life (Yrs.)		1.72			1.38
Expected volatility		3.73	%		—	%
Redemption Price	$	—		$	10.55
Stock Price	$	10.48		$	10.41

The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis for the three and six months ended June 30, 2023:


	Forward Purchase
	Agreement
Fair value as of January 1, 2023	$	—
Initial measurement on January 10, 2023 – Issuance		430,021
Change in Fair Value		(43,101)
Fair value as of March 31, 2023	$	386,920
Change in Fair Value		210,365
Fair value as of June 30, 2023	$	597,285

NOTE 9 — SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review the Company did not identify any subsequent events, other than below, that would have required adjustment or disclosure in the unaudited condensed financial statements.

Subsequent to the approval by its stockholders of the Second Amendment (the “Charter Amendment”) to the Second Amended and Restated Certificate of Incorporation of the Company on July 6, 2023, the Company filed on July 11, 2023 the Charter Amendment with the Delaware Secretary of State. The Charter Amendment extends the date by which the Company has to consummate a business combination (the “Extension”), from July 11, 2023, to January 11, 2024.

On July 9, 2023, the Company’s stockholders elected to redeem an aggregate of 464,811 shares requiring payment out of the Trust Account of approximately $4,893,007.

On July 27, 2023, the Company entered into a promissory note with Cycurion for $200,000, pursuant to which the Company can borrow up to an aggregate principal amount of $200,000. The Promissory Note is interest bearing and payable upon consummation of a Business Combination. As of the filing of this report, the Company has borrowed $200,000.

Table of Contents

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this Report to “our,” “we,” “us” or the “Company” refer to Western Acquisition Ventures Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Western Acquisition Ventures Sponsor LLC. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited condensed financial statements and the notes related thereto contained elsewhere in this Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

All statements other than statements of historical fact included in this Report including, without limitation, statements under this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Report words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of many factors, including those set forth under “Forward Looking Statements” above and “Item 1A. Risk Factors” in our 2022 Annual Report.

Overview

We are a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more target businesses (a “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of our initial public offering (“IPO”) and the sale of the placement units that occurred simultaneously with the completion of our IPO, our capital stock, debt or a combination of cash, stock, and debt.

We have identified an acquisition target and, as described in further detail below, executed a merger agreement with the intention of closing a Business Combination on or before the time allotted to do so. We expect to continue to incur significant costs in the pursuit of these acquisition plans and cannot assure you that we will be successful. The information that follows under the heading “Proposed Business Combination” and elsewhere in this Management’s Discussion and Analysis of Financial Condition and Results of Operations is intended to provide information relevant to assess the Company from our management’s perspective regarding the Company.

Proposed Business Combination

Business Combination Agreement

On November 21, 2022, the Company., WAV Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Registrant (“Merger Sub”), which will be formed at, or prior to, closing, Cycurion, Inc., a corporation organized under the laws of Ontario (“Cycurion”), and Emmit McHenry as Cycurion stockholders’ representation (the “Stockholders’ Representative”), entered into an Agreement and Plan of Merger (“Merger Agreement”) pursuant to which, among other things, Cycurion will be merged with the Merger Sub (the “Merger,” and together with the other transactions related thereto, the “Proposed Transactions”), with Cycurion surviving the Merger as a wholly-owned subsidiary of Registrant (the “Surviving Corporation”). There is no guarantee that a merger will take place.

Sponsor Support Agreement

Stockholder Support Agreement

Contemporaneously with the execution of the Merger Agreement, certain officers and directors of the Company delivered Support Agreements, pursuant to which, among other things, the Company stockholders agreed to vote in favor of the Merger and the transactions contemplated by the Merger Agreement. In addition, the Company agreed to use its best efforts to obtain additional Support Agreements from certain of its stockholders.

Table of Contents

Registration Rights Agreement

Termination

The Merger Agreement may be terminated at any time prior to the consummation of the Merger by mutual written consent of Cycurion, as applicable, and Company and in certain other limited circumstances, including if the Merger has not been consummated by January 11, 2024. Either the Company or Cycurion may also terminate the Merger Agreement if certain Proposals fail to receive the requisite vote for approval and other conditions, as defined in the Merger Agreement are not met. If the Merger Agreement is terminated, the Merger Agreement, and all above agreements, will become void, and there will be no liability under the Merger Agreement on the part of any party thereto, except as set forth in the Merger Agreement.

Results of Operations

We have neither engaged in any operations nor generated any operating revenues to date. Our only activities for the three months ended June 30, 2023 were organizational activities and the search for a prospective Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination at the earliest. We generate non-operating income in the form of interest income from the proceeds of the IPO placed in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

For the three months ended June 30, 2023, we had a net loss of $332,537. This consisted of $216,126 in professional fees, general and administrative expenses, income tax expense and franchise taxes and $93,954 of interest income on marketable securities in the Trust Account and $210,365 of change in fair value of the forward purchase agreement.

For the three months ended June 30, 2022, we had a net loss of $722,400. This consisted of $881,761 in professional fees, general and administrative expenses, and franchise taxes and $159,361 of interest income on marketable securities in the Trust Account.

For the six months ended June 30, 2023, we had a net loss of $504,148. This consisted of $619,998 in professional fees, general and administrative expenses, income tax expense and franchise taxes and $283,114 of interest income on marketable securities in the Trust Account and $167,264 of change in fair value of the forward purchase agreement.

For the six months ended June 30, 2022, we had a net loss of $1,312,809. This consisted of $1,412,448 in professional fees, general and administrative expenses, and franchise taxes and $99,639 of net gain on marketable securities in the Trust Account.

Liquidity and Capital Resources

As of June 30, 2023, we had $258,551 in cash held outside of the Trust Account. As of June 30, 2023, we had a working capital deficit of $2,191,908. The Company’s liquidity needs may need to be satisfied through the proceeds from loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties held outside of the Trust Account. The Company’s officers, directors, and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing.

For the six months ended June 30, 2023, net cash used in operating activities was $490,930, which is primarily due to a net loss of $504,148, change in fair value of forward purchase agreement of $167,264, interest income on marketable securities of $283,114, and changes in operating assets and liabilities of $129,068. Net cash provided by investing activities was $109,376,586, which was due to the withdrawal from the Trust Account to pay redeeming shareholders of $109,436,586 offset by $60,000 deposited into the Trust Account. Net cash used in financing activities was $109,436,586 which was due to the payment made for the redemption of shares.

For the six months ended June 30, 2022, net cash used in operating activities was $984,354, which is primarily due to a net loss of $1,312,809, changes in working capital of $428,094 and interest income on marketable securities of $99,639. Net cash used in investing

Table of Contents

activities was $116,150,000, which was due to the proceeds of the IPO deposited into the Trust Account. Net cash provided by financing activities was $117,749,000 which was primarily due to the IPO proceeds and the proceeds from private placement.

We have incurred, and expect to continue to incur, significant costs in pursuit of our acquisition plans. We may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of public shares upon completion of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Going Concern

In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution described in Note 1 to the unaudited condensed financial statements included in this quarterly report on Form 10-Q, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance of these financial statements.

JOBS Act

The Jumpstart Our Business Startup Act (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our IPO or until we are no longer an “emerging growth company,” whichever is earlier.

Contractual Obligations

Registration Rights

The holders of Founder Shares, Private Placement Units and units that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

Table of Contents

Business Combination Marketing Agreement

The Company has engaged A.G.P. as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholders’ approval for a Business Combination, and assist the Company with its press releases and public filings in connection with a Business Combination. The Company will pay A.G.P. a fee for such marketing services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds of the IPO, or $5,175,000 in the aggregate (exclusive of any applicable finders’ fees that might become payable). In connection with the Business Combination contemplated with Cycurion, A.G.P., and the Company amended the fee arrangement whereby rather than the cash fee described above, the Company will distribute 250,000 shares of common stock.

Forward Purchase Agreement

On January 10, 2023, the Company, Cycurion, and Alpha, entered into a Forward Share Purchase Agreement (the “FPA”). Prior to effecting the FPA, Alpha had purchased shares from an unaffiliated party which had elected to redeem 300,000 shares of Common Stock, par value $0.0001 per share (such purchased Shares, the “Recycled Shares”.) Under the terms of the FPA, once the proposed Business Combination is effective, and twelve months (or six to nine months if submitted in writing to the Company) have elapsed, Alpha may elect to sell and transfer to the Company up to that number of shares that are then held by Alpha, and the Company shall purchase from Alpha, up to that number of shares that are then held by Alpha, but not to exceed 300,000 shares in the aggregate unless otherwise agreed to in writing by all parties, at a price per share equal to the Redemption Price (as defined in the charter.)

Critical Accounting Policies

The preparation of unaudited condensed financial statements and related disclosures in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates.

Net Income/Loss per Common Share

Net loss per share is computed by dividing net income or loss by the weighted average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture by the Sponsor. The 11,876,000 potential shares of common stock for outstanding Public Warrants and Private Placement Warrants to purchase the Company’s stock were excluded from diluted earnings per share for the periods ended June 30, 2023 and 2022 because they are contingently exercisable, and the contingencies have not yet been met. Therefore, as of June 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that

Table of Contents

could, potentially, be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted income or loss per share is the same as basic loss per share for the periods presented.

Accounting for Warrants

Derivative liabilities - Forward Purchase Agreement

The Company accounts for its Forward Purchase Agreement (“FPA”) (see Note 6) in accordance with the guidance contained in ASC 815-40, “Derivatives and Hedging”, under which the FPA does not meet the criteria for equity treatment and must be recorded as a liability. Accordingly, the Company classified the FPA as a liability at its fair value and adjusts the FPA to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The FPA is valued using PWERM and certain components of the FPA are valued under the Monte Carlo model.

Table of Contents

Common Stock subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Public Shares sold in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, on January 14, 2022, 11,500,000 shares of common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

Recent Accounting Pronouncements

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to the quantitative and qualitative disclosures about market risk disclosed in our 2022 Annual Report.

Item 4. CONTROLS AND PROCEDURES

Evaluation of our Disclosure Controls and Procedures

As of June 30, 2023, an evaluation of the effectiveness of our “disclosure controls and procedures” (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) was carried out by our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”). Based upon that evaluation, the CEO and CFO have concluded that as of June 30, 2023, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) accumulated and communicated to the management of the registrant, including the CEO and CFO, to allow timely decisions regarding required disclosure.

It should also be noted that the CEO and CFO believe that our disclosure controls and procedures provide a reasonable assurance that they are effective, and they do not expect that our disclosure controls and procedures or internal control over financial reporting will prevent all errors and fraud. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

Changes in Internal Controls Over Financial Reporting

There were no changes in the Company’s internal controls over financial reporting that occurred during the second quarter of the fiscal year that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

We may be subject to legal proceedings, investigations and claims incidental to the conduct of our business from time to time. We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

Item 1A. RISK FACTORS

Not applicable to smaller reporting companies.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of equity securities during the quarter ended June 30, 2023.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

None.

Table of Contents

Item 6. Exhibits

Exhibit Index


Exhibit No.		Description
31.1*		Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*		Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
32.1**		Certification pursuant to 18 U.S.C. 1350
32.2**		Certification pursuant to 18 U.S.C. 1350
101.INS*		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
Exhibit 104*		Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

*Filed herewith

**Furnished herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WESTERN ACQUISITION VENTURES CORP.

Date: August 21, 2023	/s/ Stephen Christoffersen
	Stephen Christoffersen
	Chief Executive Officer
	(Principal Executive Officer)

Date: August 21, 2023	/s/ William Lischak
	William Lischak
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Exhibit 31.1

CERTIFICATIONS

I, Stephen Christoffersen, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Western Acquisition Ventures Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 21, 2023	By:	/s/ Stephen Christoffersen
		Stephen Christoffersen
		Chief Executive Officer
		(Principal Executive Officer)

Exhibit 31.2

CERTIFICATIONS

I, William Lischak, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Western Acquisition Ventures Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 21, 2023	By:	/s/ William Lischak
		William Lischak
		Chief Financial Officer
		(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Western Acquisition Ventures Corp. (the “Company”) for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Stephen Christoffersen, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: August 21, 2023	By:	/s/ Stephen Christoffersen
		Stephen Christoffersen
		Chief Executive Officer
		(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Western Acquisition Ventures Corp. (the “Company”) for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, William Lischak, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

Date: August 21, 2023	By:	/s/ William Lischak
		William Lischak
		Chief Financial Officer
		(Principal Financial Officer)

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2023	Aug. 21, 2023
Document Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-41214
Entity Registrant Name	Western Acquisition Ventures Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-3720717
Entity Address, Address Line One	42 Broadway, 12th Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10004
City Area Code	310
Local Phone Number	740-0710
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		3,556,410
Entity Central Index Key	0001868419
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock
Document Entity Information
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	WAVS
Security Exchange Name	NASDAQ
Warrants
Document Entity Information
Title of 12(b) Security	Warrants
Trading Symbol	WAVSW
Security Exchange Name	NASDAQ
Units, each consisting of one share of Common Stock and one Warrant to acquire one share of Common Stock
Document Entity Information
Title of 12(b) Security	Units, each consisting of one share of Common Stock and one Warrant to acquire one share of Common Stock
Trading Symbol	WAVSU
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash	$ 258,551	$ 809,481
Prepaid expenses and other assets	188,075	268,208
Total current assets	446,626	1,077,689
Prepaid expenses - non current		17,868
Investments held in Trust Account	8,097,937	117,191,410
TOTAL ASSETS	8,544,563	118,286,967
CURRENT LIABILITIES
Accounts payable and accrued expenses	946,883	829,440
Derivative liability-Forward Purchase Agreement	597,285
Excise tax payable	1,094,366
Income tax payable	305,562	250,739
Franchise tax payable	22,000	163,200
Total liabilities	2,966,096	1,243,379
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock; $0.0001 par value; 50,000,000 shares authorized; 3,251,000 shares issued and outstanding (excluding 770,221 shares and 11,500,000 shares, respectively, subject to possible redemption) as of June 30, 2023 and December 31, 2022	324	324
Additional paid-in capital		1,605,560
Accumulated deficit	(2,551,440)	(1,862,271)
Total stockholders' deficit	(2,551,116)	(256,387)
TOTAL LIABILITIES, REDEEMABLE COMMON STOCK AND STOCKHOLDERS' DEFICIT	8,544,563	118,286,967
Common stock subject to possible redemption
CURRENT LIABILITIES
Common stock subject to possible redemption, $0.0001 par value, 770,221 shares and 11,500,000 shares at redemption value of approximately $10.55 and $10.20 per share as of June 30, 2023 and December 31, 2022, respectively	$ 8,129,583	$ 117,299,975

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Common stock subject to possible redemption, redemption price per share	$ 10.10
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	3,251,000	3,251,000
Common stock, shares outstanding	3,251,000	3,251,000
Common stock subject to possible redemption
Common stock subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock subject to possible redemption, shares issued	770,221	11,500,000
Common stock subject to possible redemption, shares outstanding	770,221	11,500,000
Common stock subject to possible redemption, redemption price per share	$ 10.55	$ 10.20
Common stock, shares outstanding		11,500,000

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
OPERATING EXPENSES
Professional fees and other expenses	$ (187,706)	$ (831,761)	$ (543,125)	$ (1,316,609)
Franchise tax	(11,000)	(50,000)	(22,050)	(95,839)
LOSS FROM OPERATIONS	(198,706)	(881,761)	(565,175)	(1,412,448)
Other (expense) income:
Interest earned and unrealized loss on marketable securities held in Trust Account	93,954	159,361	283,114	99,639
Change in fair value of forward purchase agreement	(210,365)		(167,264)
TOTAL OTHER (LOSS) INCOME BEFORE TAXES	(315,117)	(722,400)	(449,325)	(1,312,809)
Income Tax Expense	(17,420)		(54,823)
NET LOSS	$ (332,537)	$ (722,400)	$ (504,148)	$ (1,312,809)
Common stock subject to possible redemption
Other (expense) income:
Basic Weighted average shares outstanding	770,221	11,500,000	1,363,026	10,610,497
Diluted Weighted average shares outstanding	770,221	11,500,000	1,363,026	10,610,497
Basic net loss per share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Diluted net loss per share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Common stock not subject to possible redemption
Other (expense) income:
Basic Weighted average shares outstanding	3,251,000	3,251,000	3,251,000	3,221,917
Diluted Weighted average shares outstanding	3,251,000	3,251,000	3,251,000	3,221,917
Basic net loss per share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Diluted net loss per share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)	Common Stock	Additional paid-in capital	Accumulated deficit	Total
Balance at the beginning at Dec. 31, 2021	$ 287	$ 24,713	$ (11,371)	$ 13,629
Balance at the beginning (in shares) at Dec. 31, 2021	2,875,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of private placement units including over-allotment	$ 37	3,759,963		3,760,000
Sale of private placement units including over-allotment (in shares)	376,000
Proceeds allocated to public warrants, net of offering costs		3,533,617		3,533,617
Accretion of Common Stock subject to possible redemption to redemption value		(5,712,733)		(5,712,733)
Net loss			(590,409)	(590,409)
Balance at the end at Mar. 31, 2022	$ 324	1,605,560	(601,780)	1,004,104
Balance at the end (in shares) at Mar. 31, 2022	3,251,000
Balance at the beginning at Dec. 31, 2021	$ 287	24,713	(11,371)	13,629
Balance at the beginning (in shares) at Dec. 31, 2021	2,875,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(1,312,809)
Balance at the end at Jun. 30, 2022	$ 324	1,605,560	(1,324,180)	281,704
Balance at the end (in shares) at Jun. 30, 2022	3,251,000
Balance at the beginning at Mar. 31, 2022	$ 324	1,605,560	(601,780)	1,004,104
Balance at the beginning (in shares) at Mar. 31, 2022	3,251,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(722,400)	(722,400)
Balance at the end at Jun. 30, 2022	$ 324	1,605,560	(1,324,180)	281,704
Balance at the end (in shares) at Jun. 30, 2022	3,251,000
Balance at the beginning at Dec. 31, 2022	$ 324	1,605,560	(1,862,271)	(256,387)
Balance at the beginning (in shares) at Dec. 31, 2022	3,251,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Forward purchase agreement		(430,021)		(430,021)
Excise tax liability arising from redemption of shares		(1,094,366)		(1,094,366)
Accretion of Common Stock subject to possible redemption to redemption value		(81,173)	(89,488)	(170,661)
Net loss			(171,611)	(171,611)
Balance at the end at Mar. 31, 2023	$ 324		(2,123,370)	(2,123,046)
Balance at the end (in shares) at Mar. 31, 2023	3,251,000
Balance at the beginning at Dec. 31, 2022	$ 324	$ 1,605,560	(1,862,271)	(256,387)
Balance at the beginning (in shares) at Dec. 31, 2022	3,251,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(504,148)
Balance at the end at Jun. 30, 2023	$ 324		(2,551,440)	(2,551,116)
Balance at the end (in shares) at Jun. 30, 2023	3,251,000
Balance at the beginning at Mar. 31, 2023	$ 324		(2,123,370)	(2,123,046)
Balance at the beginning (in shares) at Mar. 31, 2023	3,251,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Common Stock subject to possible redemption to redemption value			(95,533)	(95,533)
Net loss			(332,537)	(332,537)
Balance at the end at Jun. 30, 2023	$ 324		$ (2,551,440)	$ (2,551,116)
Balance at the end (in shares) at Jun. 30, 2023	3,251,000

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2023	Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (504,148)	$ (1,312,809)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned and unrealized loss on marketable securities held in Trust Account	(283,114)	(99,639)
Change in fair value of derivative liability - Forward Purchase Agreement	167,264
Changes in operating assets and liabilities:
Prepaid expenses and other assets	98,001	(441,033)
Accounts payable, accrued expenses and income tax payable	172,267	775,784
Franchise tax payable	(141,200)	93,343
Net cash used in operating activities	(490,930)	(984,354)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash deposited to Trust Account	(60,000)	(116,150,000)
Cash withdrawn from Trust Account in connection with redemption	109,436,586
Net cash provided by (used in) investing activities	109,376,586	(116,150,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from initial public offering, net of underwriters' discount		114,500,000
Proceeds from private placement		3,760,000
Redemption of Common Stock	(109,436,586)
Payment of Sponsor loan		(80,000)
Payment of offering costs		(431,000)
Net cash (used in) provided by financing activities	(109,436,586)	117,749,000
NET CHANGE IN CASH	(550,930)	614,646
CASH, BEGINNING OF PERIOD	809,481	3,913
CASH, END OF PERIOD	258,551	618,559
Supplemental disclosure of noncash activities:
Issuance of Forward Purchase Agreement	430,021
Excise tax liability arising from redemption of shares	1,094,366
Accretion of common stock subject to redemption value	$ 266,194	$ 5,712,733

Description of Organization and Business Operations and Liquidity

6 Months Ended

Jun. 30, 2023

Description of Organization and Business Operations and Liquidity

Description of Organization and Business Operations and Liquidity

Note 1 – Description of Organization and Business Operations and Liquidity

Risks and Uncertainties

Business Combination Agreement

Sponsor Support Agreement

Stockholder Support Agreement

Registration Rights Agreement

Termination

Liquidity and Capital Resources

As of June 30, 2023, the Company had $258,551 in its operating bank accounts, and a working capital deficit of $2,191,908.

Going Concern

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Investments Held in Trust Account

Common Stock subject to Possible Redemption

As of June 30, 2023 and December 31, 2022, the value of common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Gross proceeds	$	115,000,000
Less:
Proceeds allocated to Public Warrants		(3,565,000)
Issuance costs allocated to Public Shares		(997,733)
Plus:
Accretion of carrying value to redemption value		6,862,708
Common stock subject to possible redemption as of December 31, 2022	$	117,299,975
Less:
Redemption		(109,436,586)
Add:
Accretion of carrying value to redemption value		170,661
Common stock subject to possible redemption as of March 31, 2023	$	8,034,050
Add:
Accretion of carrying value to redemption value		95,533
Common stock subject to possible redemption as of June 30, 2023	$	8,129,583

Deferred Offering Costs Associated with the Initial Public Offering

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value of Derivative Liabilities – Forward Purchase Agreement

Income Taxes

Net Loss per Common Stock Share

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30,								Six Months Ended June 30,
	2023				2022				2023				2022
	Common		Common		Common		Common		Common		Common		Common		Common
	stock		stock not		stock		stock not		stock		stock not		stock		stock not
	subject to		subject to		subject to		subject to		subject to		subject to		subject to		subject to
	possible		possible		possible		possible		possible		possible		possible		possible
	redemption		redemption		redemption		redemption		redemption		redemption		redemption		redemption
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(63,694)	$	(268,843)	$	(563,189)	$	(159,211)	$	(148,930)	$	(355,218)	$	(1,007,023)	$	(305,786)
Denominator:
Basic and diluted weighted average shares outstanding		770,221		3,251,000		11,500,000		3,251,000		1,363,026		3,251,000		10,610,497		3,221,917
Basic and diluted net loss per ordinary share	$	(0.08)	$	(0.08)	$	(0.05)	$	(0.05)	$	(0.11)	$	(0.11)	$	(0.09)	$	(0.09)

Accounting for Warrants

Recent Accounting Pronouncements

INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

6 Months Ended

Jun. 30, 2023

INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

NOTE 3 — INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT

PRIVATE PLACEMENT UNITS

6 Months Ended

Jun. 30, 2023

PRIVATE PLACEMENT UNITS

PRIVATE PLACEMENT UNITS

NOTE 4 — PRIVATE PLACEMENT UNITS

RELATED PARTY TRANSACTIONS

6 Months Ended

Jun. 30, 2023

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

NOTE 5 — RELATED PARTY TRANSACTIONS

Founder Shares

Promissory Note – Related Party

Related Party Loans

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2023

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

NOTE 6 — COMMITMENTS AND CONTINGENCIES

Registration Rights

Underwriting Agreement

Business Combination Marketing Agreement

Forward Purchase Agreement

Inflation Reduction Act of 2022 (the “IR Act”)

STOCKHOLDERS' DEFICIT

6 Months Ended

Jun. 30, 2023

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT

NOTE 7 — STOCKHOLDERS’ DEFICIT

The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

●

in whole and not in part;

●

at a price of $0.01 per Public Warrant;

●

upon not less than 30 days’ prior written notice of redemption;

●

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.

FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2023

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

NOTE 8 — FAIR VALUE MEASUREMENTS

Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement.


			Quoted		Significant		Significant
			Prices In		Other		Other
			Active		Observable		Unobservable
	June 30,		Markets		Inputs		Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	8,097,937	$	8,097,937	$	—	$	—
Liabilities:
Derivative Liability - Forward Purchase Agreement	$	597,285	$	—	$	—	$	597,285

Quoted

Significant

Prices In

Other

Active

Observable

Unobservable

December 31,

Markets

Inputs

2022

(Level 1)

(Level 2)

(Level 3)

Assets:

U.S. Money Market held in Trust Account

117,191,410

—

The key inputs of the models used to value the Company’s FPA were as follows:


	Initial Measurement Date of
Input	January 10, 2023			June 30, 2023
Risk-free interest rate		4.63	%		5.42	%
Remaining life (Yrs.)		1.72			1.38
Expected volatility		3.73	%		—	%
Redemption Price	$	—		$	10.55
Stock Price	$	10.48		$	10.41


	Forward Purchase
	Agreement
Fair value as of January 1, 2023	$	—
Initial measurement on January 10, 2023 – Issuance		430,021
Change in Fair Value		(43,101)
Fair value as of March 31, 2023	$	386,920
Change in Fair Value		210,365
Fair value as of June 30, 2023	$	597,285

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2023

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 9 — SUBSEQUENT EVENTS

On July 9, 2023, the Company’s stockholders elected to redeem an aggregate of 464,811 shares requiring payment out of the Trust Account of approximately $4,893,007.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Basis of Presentation

Basis of Presentation

Emerging Growth Company

Use of Estimates

Cash and Cash Equivalents

Investments Held in Trust Account

Common Stock subject to Possible Redemption

As of June 30, 2023 and December 31, 2022, the value of common stock subject to possible redemption reflected on the balance sheet is reconciled on the following table:


Gross proceeds	$	115,000,000
Less:
Proceeds allocated to Public Warrants		(3,565,000)
Issuance costs allocated to Public Shares		(997,733)
Plus:
Accretion of carrying value to redemption value		6,862,708
Common stock subject to possible redemption as of December 31, 2022	$	117,299,975
Less:
Redemption		(109,436,586)
Add:
Accretion of carrying value to redemption value		170,661
Common stock subject to possible redemption as of March 31, 2023	$	8,034,050
Add:
Accretion of carrying value to redemption value		95,533
Common stock subject to possible redemption as of June 30, 2023	$	8,129,583

Deferred Offering Costs Associated with the Initial Public Offering

Concentration of Credit Risk

Fair Value of Financial Instruments

Fair Value of Derivative Liabilities - Forward Purchase Agreement

Fair Value of Derivative Liabilities – Forward Purchase Agreement

Income Taxes

Net Loss per Common Stock Share

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30,								Six Months Ended June 30,
	2023				2022				2023				2022
	Common		Common		Common		Common		Common		Common		Common		Common
	stock		stock not		stock		stock not		stock		stock not		stock		stock not
	subject to		subject to		subject to		subject to		subject to		subject to		subject to		subject to
	possible		possible		possible		possible		possible		possible		possible		possible
	redemption		redemption		redemption		redemption		redemption		redemption		redemption		redemption
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(63,694)	$	(268,843)	$	(563,189)	$	(159,211)	$	(148,930)	$	(355,218)	$	(1,007,023)	$	(305,786)
Denominator:
Basic and diluted weighted average shares outstanding		770,221		3,251,000		11,500,000		3,251,000		1,363,026		3,251,000		10,610,497		3,221,917
Basic and diluted net loss per ordinary share	$	(0.08)	$	(0.08)	$	(0.05)	$	(0.05)	$	(0.11)	$	(0.11)	$	(0.09)	$	(0.09)

Accounting for Warrants

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies

Schedule of reconciliation of common stock subject to possible redemption reflected on balance sheet


Gross proceeds	$	115,000,000
Less:
Proceeds allocated to Public Warrants		(3,565,000)
Issuance costs allocated to Public Shares		(997,733)
Plus:
Accretion of carrying value to redemption value		6,862,708
Common stock subject to possible redemption as of December 31, 2022	$	117,299,975
Less:
Redemption		(109,436,586)
Add:
Accretion of carrying value to redemption value		170,661
Common stock subject to possible redemption as of March 31, 2023	$	8,034,050
Add:
Accretion of carrying value to redemption value		95,533
Common stock subject to possible redemption as of June 30, 2023	$	8,129,583

Schedule of calculation of basic and diluted net income (loss) per ordinary share

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):


	Three Months Ended June 30,								Six Months Ended June 30,
	2023				2022				2023				2022
	Common		Common		Common		Common		Common		Common		Common		Common
	stock		stock not		stock		stock not		stock		stock not		stock		stock not
	subject to		subject to		subject to		subject to		subject to		subject to		subject to		subject to
	possible		possible		possible		possible		possible		possible		possible		possible
	redemption		redemption		redemption		redemption		redemption		redemption		redemption		redemption
Basic and diluted net loss per share:
Numerator:
Allocation of net loss	$	(63,694)	$	(268,843)	$	(563,189)	$	(159,211)	$	(148,930)	$	(355,218)	$	(1,007,023)	$	(305,786)
Denominator:
Basic and diluted weighted average shares outstanding		770,221		3,251,000		11,500,000		3,251,000		1,363,026		3,251,000		10,610,497		3,221,917
Basic and diluted net loss per ordinary share	$	(0.08)	$	(0.08)	$	(0.05)	$	(0.05)	$	(0.11)	$	(0.11)	$	(0.09)	$	(0.09)

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2023

FAIR VALUE MEASUREMENTS

Schedule of assets and liabilities measured at fair value on a recurring basis


			Quoted		Significant		Significant
			Prices In		Other		Other
			Active		Observable		Unobservable
	June 30,		Markets		Inputs		Inputs
	2023		(Level 1)		(Level 2)		(Level 3)
Assets:
U.S. Money Market held in Trust Account	$	8,097,937	$	8,097,937	$	—	$	—
Liabilities:
Derivative Liability - Forward Purchase Agreement	$	597,285	$	—	$	—	$	597,285

Quoted

Significant

Prices In

Other

Active

Observable

Unobservable

December 31,

Markets

Inputs

2022

(Level 1)

(Level 2)

(Level 3)

Assets:

U.S. Money Market held in Trust Account

117,191,410

—

Schedule of key inputs of the models used to value the Company's FPA


	Initial Measurement Date of
Input	January 10, 2023			June 30, 2023
Risk-free interest rate		4.63	%		5.42	%
Remaining life (Yrs.)		1.72			1.38
Expected volatility		3.73	%		—	%
Redemption Price	$	—		$	10.55
Stock Price	$	10.48		$	10.41

Schedule of changes in the fair value of warrant liabilities


	Forward Purchase
	Agreement
Fair value as of January 1, 2023	$	—
Initial measurement on January 10, 2023 – Issuance		430,021
Change in Fair Value		(43,101)
Fair value as of March 31, 2023	$	386,920
Change in Fair Value		210,365
Fair value as of June 30, 2023	$	597,285

Description of Organization and Business Operations and Liquidity (Details)				3 Months Ended	6 Months Ended	12 Months Ended
	Apr. 03, 2023 USD ($) item	Jan. 06, 2023 USD ($) item $ / shares shares	Jan. 14, 2022 USD ($) $ / shares shares	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($) D $ / shares shares	Dec. 31, 2022 USD ($) $ / shares	Jul. 09, 2023 USD ($)
Description of Organization and Business Operations and Liquidity
Number of units issued \| shares			11,500,000
Unit price \| $ / shares			$ 10.10
Proceeds from issuance of units			$ 116,150,000
Number of shares of common stock to be issued \| shares					250,000
Percentage of assets held in trust required					80.00%
Percentage of post transaction ownership required					50.00%
Common stock subject to possible redemption, redemption price per share \| $ / shares					$ 10.10
Minimum amount of net intangible assets					$ 5,000,001
Percentage of shares subject to lockup provision					15.00%
Percentage of commitment redemption					100.00%
Maximum number of times for extension of the date by which the company has to consummate business combination \| item		6
Additional extension period each time for the company to consummate business combination		1 month
Deposit into the Trust Account for each one-month extension		$ 10,000
Number of days from closing of IPO for shares redemption \| D					10
Maximum amount of dissolution expenses					$ 100,000
Share price per share \| $ / shares		$ 10.20			$ 10.10
Minimum net tangible assets upon consummation of the Business Combination	$ 50,000,000
Minimum Number of beneficial owners of its shares \| item	300
Bank balance					$ 258,551
Working capital deficit					$ 2,191,908
Common stock subject to possible redemption
Description of Organization and Business Operations and Liquidity
Proceeds from issuance of units						$ 115,000,000
Common stock subject to possible redemption, redemption price per share \| $ / shares					$ 10.55	$ 10.20
Number of shares redeemed \| shares		10,729,779
Value of shares redeemed		$ 109,436,586		$ (109,436,586)
Subsequent event
Description of Organization and Business Operations and Liquidity
Payment of a nominal fee							$ 100
IPO
Description of Organization and Business Operations and Liquidity
Number of units issued \| shares			10,000,000
Unit price \| $ / shares			$ 10.00
Proceeds from issuance of units			$ 100,000,000
Number of shares in a unit \| shares			1
Number of warrants in a unit \| shares			1
Number of shares issuable per warrant (in shares) \| shares			1
Exercise price of warrant \| $ / shares			$ 11.50
Aggregate offering cost					$ 1,029,116
Underwriters fees					500,000
Other offering cost					$ 529,116
Percentage of marketing agreement fees payable					4.50%
Aggregate amount due to A.G.P					$ 5,175,000
Over-allotment Units
Description of Organization and Business Operations and Liquidity
Number of units issued \| shares			1,500,000		1,500,000
Unit price \| $ / shares			$ 10.00
Proceeds from issuance of units			$ 15,000,000
Private Placement
Description of Organization and Business Operations and Liquidity
Number of units issued \| shares			361,000
Unit price \| $ / shares			$ 10.00
Proceeds from issuance of units			$ 3,610,000
Number of shares in a unit \| shares			1
Number of warrants in a unit \| shares			1
Exercise price of warrant \| $ / shares			$ 11.50
Private Placement \| Western Acquisition Ventures Sponsor LLC
Description of Organization and Business Operations and Liquidity
Number of units issued \| shares			15,000
Proceeds from issuance of units			$ 150,000

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jan. 14, 2022
Summary of Significant Accounting Policies
Cash	$ 258,551		$ 258,551		$ 809,481
Cash equivalents	0		0		0
Common stock subject to possible redemption, shares outstanding						11,500,000
Deferred offering costs	0		0		$ 0
Federal depositary insurance coverage	$ 250,000		$ 250,000
Effective tax rate	(5.53%)	0.00%	(12.20%)	0.00%
Statutory tax rate	21.00%	21.00%	21.00%	21.00%
Unrecognized tax benefits	$ 0	$ 0	$ 0	$ 0
Unrecognized tax benefits, income tax penalties and interest accrued	$ 0		$ 0

Summary of Significant Accounting Policies - Common stock subject to possible redemption reflected on the balance sheet (Details) - USD ($)			3 Months Ended		12 Months Ended
	Jan. 06, 2023	Jan. 14, 2022	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies
Gross proceeds		$ 116,150,000
Plus:
Shares subject to possible redemption		11,500,000
Common stock subject to possible redemption
Summary of Significant Accounting Policies
Gross proceeds					$ 115,000,000
Less:
Proceeds allocated to Public Warrants					(3,565,000)
Issuance costs allocated to Public Shares					(997,733)
Redemption	$ 109,436,586			$ (109,436,586)
Plus:
Accretion of carrying value to redemption value			$ 95,533	170,661	6,862,708
Common stock subject to possible redemption			$ 8,129,583	$ 8,034,050	$ 117,299,975
Shares subject to possible redemption			770,221		11,500,000

Summary of Significant Accounting Policies - Reconciliation of net loss per ordinary shares (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Numerator:
Shares excluded from calculation of diluted loss per share	11,876,000	11,876,000	11,876,000	11,876,000
Founder Shares
Numerator:
Weighted average number of shares, common stock subject to repurchase or cancellation			375,000
Common stock subject to possible redemption
Numerator:
Allocation of net loss, Basic	$ (63,694)	$ (563,189)	$ (148,930)	$ (1,007,023)
Allocation of net loss, Diluted	$ (63,694)	$ (563,189)	$ (148,930)	$ (1,007,023)
Basic weighted average shares outstanding	770,221	11,500,000	1,363,026	10,610,497
Diluted weighted average shares outstanding	770,221	11,500,000	1,363,026	10,610,497
Basic net loss per ordinary share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Diluted net loss per ordinary share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Common stock not subject to possible redemption
Numerator:
Allocation of net loss, Basic	$ (268,843)	$ (159,211)	$ (355,218)	$ (305,786)
Allocation of net loss, Diluted	$ (268,843)	$ (159,211)	$ (355,218)	$ (305,786)
Basic weighted average shares outstanding	3,251,000	3,251,000	3,251,000	3,221,917
Diluted weighted average shares outstanding	3,251,000	3,251,000	3,251,000	3,221,917
Basic net loss per ordinary share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)
Diluted net loss per ordinary share	$ (0.08)	$ (0.05)	$ (0.11)	$ (0.09)

INITIAL PUBLIC OFFERING AND OVER-ALLOTMENT (Details) - $ / shares		6 Months Ended
	Jan. 14, 2022	Jun. 30, 2023
Initial Public Offering and Over-Allotment
Number of units issued	11,500,000
Price per share	$ 10.10
IPO
Initial Public Offering and Over-Allotment
Number of units issued	10,000,000
Price per share	$ 10.00
Number of shares in a unit	1
Number of warrants in a unit	1
Number of shares issuable per warrant (in shares)	1
Exercise price of warrant	$ 11.50
Over-allotment Units
Initial Public Offering and Over-Allotment
Number of units issued	1,500,000	1,500,000
Price per share	$ 10.00

PRIVATE PLACEMENT UNITS (Details) - USD ($)		6 Months Ended
PRIVATE PLACEMENT UNITS (Details) - USD ($)	Jan. 14, 2022	Jun. 30, 2022
Private Placement Units
Proceeds from private placement		$ 3,760,000
Private Placement
Private Placement Units
Number of shares issued	376,000
Price per share	$ 10.00
Proceeds from private placement	$ 3,760,000
Number of shares in a unit	1
Number of warrants in a unit	1
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS (Details)				6 Months Ended
RELATED PARTY TRANSACTIONS (Details)	Nov. 22, 2021 USD ($) shares	Jun. 16, 2021 USD ($) shares	Jun. 09, 2021 USD ($) shares	Jun. 30, 2023 $ / shares shares
Related Party Transactions
Stock split, conversion ratio	2
Founder Shares \| Related Party
Related Party Transactions
Shares subject to forfeiture	375,000
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares				$ 12.00
Restrictions on transfer period of time after business combination completion				1 year
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination				20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination				30 days
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences				150 days
Founder Shares \| Sponsor
Related Party Transactions
Number of shares issued	55,000		4,312,500	500,000
Aggregate purchase price \| $	$ 478		$ 25,000
Aggregate number of shares owned	2,125,000
Founder Shares \| Alliance Global Partners
Related Party Transactions
Number of shares transferred		1,207,500
Value of shares transferred \| $		$ 7,000
Number of Shares Sold Back to Sponsor	55,000
Value of Shares Sold Back to Sponsor \| $	$ 478
Aggregate number of shares owned	750,000

RELATED PARTY TRANSACTIONS - Related Party (Details) - USD ($)		6 Months Ended
	Jun. 09, 2021	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Loans \| Related Party
Related Party Transactions
Maximum borrowing capacity of related party promissory note		$ 1,500,000
Conversion price per share		$ 10.00
Loan outstanding amount		$ 0	$ 0
Promissory Note With Related Party \| Sponsor
Related Party Transactions
Maximum borrowing capacity of related party promissory note	$ 300,000
Notes payable, related parties, current				$ 80,000

COMMITMENTS AND CONTINGENCIES - Underwriting Agreement (Details)					6 Months Ended
	Jan. 14, 2022 $ / shares shares	Nov. 22, 2021 USD ($) shares	Jun. 16, 2021 USD ($) shares	Jun. 09, 2021 USD ($) shares	Jun. 30, 2023 shares
Commitments and Contingencies
Underwriters option period					45 days
Number of units issued	11,500,000
Unit price \| $ / shares	$ 10.10
Stock split, conversion ratio		2
Founder Shares \| Sponsor
Commitments and Contingencies
Number of shares issued		55,000		4,312,500	500,000
Aggregate purchase price \| $		$ 478		$ 25,000
Aggregate number of shares owned		2,125,000
Founder Shares \| Alliance Global Partners
Commitments and Contingencies
Number of shares transferred			1,207,500
Value of shares transferred \| $			$ 7,000
Aggregate number of shares owned		750,000
Over-allotment Units
Commitments and Contingencies
Number of units issued	1,500,000				1,500,000
Unit price \| $ / shares	$ 10.00

COMMITMENTS AND CONTINGENCIES - Business Combination Marketing Agreement (Details)	6 Months Ended
	Jun. 30, 2023 USD ($) shares
COMMITMENTS AND CONTINGENCIES
Percentage of original principal , amortization	4.50%
Proceeds from Issuance or Sale of Equity \| $	$ 5,175,000
Number of shares of common stock to be issued \| shares	250,000

COMMITMENTS AND CONTINGENCIES - Forward Purchase Agreement (Details)			3 Months Ended		6 Months Ended
	Jan. 10, 2023 USD ($) D $ / shares shares	Jan. 06, 2023 USD ($) shares	Jun. 30, 2023 USD ($) $ / shares	Mar. 31, 2023 USD ($)	Jun. 30, 2023 USD ($) $ / shares	Mar. 10, 2023 USD ($)	Dec. 31, 2022 $ / shares
COMMITMENTS AND CONTINGENCIES
Par value per common stock share of shares purchased from an unaffiliated party which had elected to redeem \| $ / shares	$ 0.0001		$ 0.0001		$ 0.0001		$ 0.0001
Derivative liability-Forward Purchase Agreement \| $	$ 430,021		$ 597,285		$ 597,285	$ 430,021
Change in fair value of derivative liability - Forward Purchase Agreement \| $			(210,365)		(167,264)
Excise tax payable \| $		$ 1,094,366	$ 1,094,366		$ 1,094,366
Excise tax payable as a percentage of shares redeemed		1.00%
Common stock subject to possible redemption
COMMITMENTS AND CONTINGENCIES
Number of shares redeemed \| shares		10,729,779
Value of shares redeemed \| $		$ 109,436,586		$ (109,436,586)
Alpha Capital Anstalt ("Alpha")
COMMITMENTS AND CONTINGENCIES
Number of common stock shares purchased from an unaffiliated party which had elected to redeem \| shares	300,000
Forward Purchase Agreement \| Alpha Capital Anstalt ("Alpha")
COMMITMENTS AND CONTINGENCIES
Period after the Business Combination that the counterparty may elect to sell and transfer to the Company up to that number of shares that are then held by such counterparty, one	12 months
Period after the Business Combination that the counterparty may elect to sell and transfer to the Company up to that number of shares that are then held by such counterparty, two	6 months
Period after the Business Combination that the counterparty may elect to sell and transfer to the Company up to that number of shares that are then held by such counterparty, three	9 months
Maximum number of shares that the Company shall purchase from counterparty \| shares	300,000
Number of calendar days written notice is to be provided to reduce the restriction period \| D	2
Maximum number of shares that the counterparty may elect to sell and transfer \| shares	300,000
Threshold number of consecutive trading period following the closing of the Business Combination over which the VWAP Price is considered for accelerating the Put Date \| D	30
Threshold trading period following the closing of the Business Combination over which the VWAP Price is considered for accelerating the Put Date \| D	20
Threshold VWAP Price considered for accelerating the Put Date \| $ / shares	$ 3.00
Maximum reimbursement of all reasonable and necessary brokerage commissions per share for acquisition of shares \| $ / shares	0.05
Maximum reimbursement of all reasonable and necessary brokerage commissions per share for disposition of shares \| $ / shares	$ 0.02
Number of business days written notice to be provided for sale of Recycled Shares by counterparty \| D	3
Reset price per share \| $ / shares	$ 8.00
Value used to multiply with VWAP Price to arrive at the adjusted Reset Price	1.05
Number of trading days over which the VWAP Price is considered for determination of adjusted Reset Price \| D	5
Minimum adjusted reset price per share \| $ / shares	$ 2.00
Number of business days within which notice of any draw on equity line of credit or similar facility is to be provided to Investor \| D	1

STOCKHOLDERS' DEFICIT - Common Stock (Details) - $ / shares	Jun. 30, 2023	Jan. 10, 2023	Dec. 31, 2022	Jan. 14, 2022
Stockholders Equity
Common shares, shares authorized (in shares)	50,000,000		50,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, shares outstanding (in shares)	3,251,000		3,251,000
Shares subject to possible redemption				11,500,000
Founder Shares
Stockholders Equity
Common shares, shares outstanding (in shares)	2,875,000		2,875,000
Private placement units
Stockholders Equity
Common shares, shares outstanding (in shares)	376,000		376,000
Common stock subject to possible redemption
Stockholders Equity
Common shares, shares outstanding (in shares)			11,500,000
Shares subject to possible redemption	770,221		11,500,000

STOCKHOLDERS' DEFICIT - Preferred Stock (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

STOCKHOLDERS' DEFICIT- Public Warrants and Private Placement Warrants (Details)	6 Months Ended
	Jun. 30, 2023 D $ / shares shares	Dec. 31, 2022 shares
Public Warrants
Warrants
Warrants outstanding \| shares	11,500,000	11,500,000
Public warrants exercisable term after the completion of a business combination	30 days
Public warrants exercisable term from the closing of the initial public offering	12 months
Warrants expire term	5 years
Redemption price per public warrant (in dollars per share) \| $ / shares	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Stock price trigger for redemption of public warrants (in dollars per share) \| $ / shares	$ 18.00
Threshold trading days for redemption of public warrants \| D	20
Threshold consecutive trading days for redemption of public warrants \| D	30
Threshold issue price for capital raising purposes in connection with the closing of a business combination \| $ / shares	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days for calculating market value \| D	20
Percentage of adjustment of two of redemption price of stock based on market value and newly issued price	115.00%
Private Placement Warrants
Warrants
Warrants outstanding \| shares	376,000	376,000

FAIR VALUE MEASUREMENTS (Details) - USD ($)	3 Months Ended	6 Months Ended
FAIR VALUE MEASUREMENTS (Details) - USD ($)	Jun. 30, 2023	Jun. 30, 2023	Mar. 10, 2023	Jan. 10, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	$ 8,097,937	$ 8,097,937			$ 117,191,410
Derivative Liability - Forward Purchase Agreement	597,285	597,285
Derivative liability-Forward Purchase Agreement	597,285	597,285	$ 430,021	$ 430,021
Change in fair value of derivative liability - Forward Purchase Agreement	210,365	167,264
Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	8,097,937	8,097,937			117,191,410
Level 1 \| Money Market Funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	8,097,937	8,097,937			$ 117,191,410
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability - Forward Purchase Agreement	$ 597,285	$ 597,285

FAIR VALUE MEASUREMENTS - Key inputs of the Put model Option to Value (Details) - FPA	Jun. 30, 2023 $ / shares Y	Jan. 10, 2023 Y $ / shares
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.0542	0.0463
Remaining life (Yrs.)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input \| Y	1.38	1.72
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input		0.0373
Redemption Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	10.55
Stock Price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	10.41	10.48

FAIR VALUE MEASUREMENTS - Changes in the fair value of warrant liabilities (Details) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2023	Jun. 30, 2023
FAIR VALUE MEASUREMENTS
Initial measurement on January 10, 2023 - Issuance	$ 430,021
Change in Fair Value	(43,101)	$ 210,365
Fair value as of March 31, 2023	$ 386,920	$ 597,285

SUBSEQUENT EVENTS (Details) - Subsequent event - USD ($)	Jul. 09, 2023	Jul. 27, 2023
SUBSEQUENT EVENTS
Aggregate number of shares, stockholders elected to redeem	464,811
Funds remaining in trust account	$ 4,893,007
Cycurion \| Promissory Note
SUBSEQUENT EVENTS
Loan amount		$ 200,000
Borrowed amount		$ 200,000